The association between lung cancer (LC) and interstitial lung disease (ILD) can be
explained by the shared risk factors like smoking and physiopathology of fibrogenesis and …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease of unknown etiology.
With a gradually increasing worldwide prevalence and a mortality rate exceeding that of …

Objective Lobectomy is a standard treatment for stage I non–small cell lung cancer, but a
significant proportion of patients are considered at high risk for complications, including …

Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is a life-
threatening complication of lung cancer operation for patients with IPF, and no effective …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with a poor prognosis and
an unknown cause that generally progresses to pulmonary fibrosis and leads to irreversible …

Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity
and mortality. Lung fibrosis can be associated with lung cancer. The pathogenesis of both …

Recognising recent advances, the definition and diagnostic criteria for acute exacerbation of
idiopathic pulmonary fibrosis (AE-IPF) have been updated by an international working …

Background and Objective Translational research is a source of continuous innovation in
medicine, more particularly for clinical research on new treatment modalities in idiopathic …

Current Opinion in Pulmonary Medicine Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Idiopathic pulmonary fibrosis (IPF) is a progressive and devastating disease with a median
survival time of 2–3 years after diagnosis. Patients with IPF exhibit distinct patterns of …